In this study, the investigator propose to determine the efficiency of a new and more sophisticated imaging prototype, the Spectral Photon Counting Computed Tomography (SPCCT), at characterizing vulnerable plaques and luminal stenosis in Carotid Atherosclerosis patients compared to DECT (Dual Energy CT) and MRI (Magnetic Resonance Imaging) which are used in current practice
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Lipid Necrotic Core (LNC) in mm² identified with SPCCT
Timeframe: 1 month
Lipid Necrotic Core (LNC) in mm² identified with DECT
Timeframe: 1 month
Lipid Necrotic Core (LNC) in mm² identified with histology
Timeframe: 1 month
Intra Plaque Hemorrhage (IPH) in mm² identified with SPCCT
Timeframe: 1 month
Intra Plaque Hemorrhage (IPH) in mm² identified with DECT
Timeframe: 1 month
Intra Plaque Hemorrhage (IPH) identified with histology
Timeframe: 1 month
Fibrous Cap Ulceration (FCU) in mm² identified with SPCCT
Timeframe: 1 month
Fibrous Cap Ulceration (FCU) in mm² identified with DECT
Timeframe: 1 month
Fibrous Cap Ulceration (FCU) in mm² identified with histology
Timeframe: 1 month